Abstract
ObjectiveTo examine the effects of two cadherin peptides, a short linear peptide containing His‐Ala‐Val (HAV) sequence and a cyclic peptide containing the Ala‐Asp‐Thr (cADT) sequence, on BBB integrity.MethodsThe effects of the HAV and cADT peptides on BBB permeability were examined in Balb/c mice. Blood‐brain barrier permeability was assessed with gadolinium contrast agent (Gad; a small hydrophilic permeability marker), IRdye 800cw PEG (a large hydrophilic permeability marker), and Rhodamine 800 (a P‐gp substrate) under control conditions and following exposure to HAV (1.0–32 mM/kg) or cADT peptides (1mM/kg) using magnetic resonance imaging (MRI) and near infrared fluorescence imaging.ResultsMice treated with HAV displayed a dose‐dependent increase in BBB permeability as assessed with Gad enhanced MRI with doses of 1.0 mM/kg having no effect and maximal increases (18‐fold) observed with 32 mM/kg. Increases in BBB permeability were also observed with IRdye 800cw PEG (3‐fold) and Rhodamine 800 (60% increase). The increase in permeability was transient (return to normal within 1 hr). Increases in BBB permeability were also observed with cADT, albeit at lower dose (1.0 mM/kg).ConclusionsCadherin peptides produced a rapid and reversible increase in BBB permeability and the combination of these peptides with therapeutic agents can enhance drug delivery to the brain.Funding:Supported by NSERC and NIH.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
